Meritage Portfolio Management »

Corcept Therapeutics Incorporated shares owned by Meritage Portfolio Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Meritage Portfolio Management from 13F filings

Historical chart of Meritage Portfolio Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Meritage Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Meritage Portfolio Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $616k 25k 25.19
2023-12-31 $853k 26k 32.47
2023-09-30 $690k 25k 27.25
2023-06-30 $560k 25k 22.25
2023-03-31 $424k 20k 21.65
2022-12-31 $399k 20k 20.29
2022-09-30 $489k 19k 25.66
2022-06-30 $438k 18k 23.78
2022-03-31 $425k 19k 22.51
2021-12-31 $208k 11k 19.81

More positions owned by Meritage Portfolio Management

Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Inc Cl A Common (GOOGL)
Broadcom Common (AVGO)
Amazon Common (AMZN)
Novo-nordisk A S Common (NVO)
Asml Holding Nv Common (ASML)
Cadence Design Systems Common (CDNS)
Fortinet Common (FTNT)
Cheniere Energy Common (LNG)
Pioneer Nat Res Common (PXD)
Mastercard Common (MA)
Spdr S&p 500 Value Etf Other Equities (SPYV)
Ametek Common (AME)
Kla Corporation Common (KLAC)

View all positions for Meritage Portfolio Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Geode Capital Management
First Trust Advisors
Btim
Federated Investors
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Man Group
Susquehanna International
Ikarian Capital
Millennium Management

View all funds holding Corcept Therapeutics Incorporated